Current issue
Archive
Manuscripts accepted
About the Journal
Editorial office
Editorial board
Section Editors
Abstracting and indexing
Subscription
Contact
Ethical standards and procedures
Most read articles
Instructions for authors
Article Processing Charge (APC)
Regulations of paying article processing charge (APC)
CARDIOLOGY / RESEARCH LETTER
Medication adherence in vascular prevention: findings from the SIFHON-ADH survey in Argentina
1
Comprehensive Stroke Center, Division of Neurology, Fleni. Buenos Aires, Argentina, Fleni, Argentina
These authors had equal contribution to this work
Submission date: 2025-11-08
Final revision date: 2026-02-02
Acceptance date: 2026-03-03
Online publication date: 2026-02-28
Publication date: 2026-02-28
Corresponding author
Arch Med Sci 2026;22(1):531-535
TOPICS
REFERENCES (23)
1.
GBD 2019 Stroke Collaborators. Global, regional, and national burden of stroke, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Neurol 2021; 20: 439-58.
2.
Ameriso S, Gomez-Schneider M, Hawkes M, et al. Prevalence of stroke in Argentina: a door-to-door population-based study (EstEPA). Int J Stroke 2021; 16: 280-7.
3.
Ameriso S, Alet M, Rosales J, et al. Incidence and case-fatality rate of stroke in General Villegas, Buenos Aires, Argentina. The EstEPA population study. J Stroke Cerebrovasc Dis 2023; 32: 107058.
4.
Chen B, Perkins H, Ehrensperger E, et al. Adherence to guidelines at a stroke prevention clinic: a follow-up study. Can J Neurol Sci 2019; 46: 57-63.
5.
Nieuwlaat R, Wilczynski N, Navarro T, et al. Interventions for enhancing medication adherence. Cochrane Database Syst Rev 2014; 2014: CD000011.
6.
Lam W, Fresco P. Medication adherence measures: an overview. Biomed Res Int 2015; 2015: 217047.
7.
Chambers J, O’Carroll R, Hamilton B, et al. Adherence to medication in stroke survivors: a qualitative comparison of low and high adherers. Br J Health Psychol 2011; 16: 592-609.
8.
Linari M, Álvaro O, Argerich M, et al. Estudio Multicéntrico: Escala De Adherencia En El Tratamiento De La Diabetes Tipo 2 Y Su Asociación Con Antecedentes Personales Aplicada En Ocho Regiones Geográficas diferentes de la República Argentina. Rev Argent Med 2019; 6: 207-12.
9.
Muñoz-Venturelli P, Sacks C, Madrid E, Lavados P. Long-term adherence to national guidelines for secondary prevention of ischemic stroke: a prospective cohort study in a public hospital in Chile. J Stroke Cerebrovasc Dis 2014; 23: 490-5.
10.
Gast A, Mathes T. Medication adherence influencing factors-an overview of systematic reviews. Syst Rev 2019; 8: 112.
11.
Miao Y, Luo Y, Zhao Y, Liu M, Wang H, Wu Y. Effectiveness of eHealth interventions in improving medication adherence among patients with cardiovascular disease: systematic review and meta-analysis. J Med Internet Res 2024; 26: e58013.
12.
Al-Arkee S, Mason J, Lane DA, et al. Mobile apps to improve medication adherence in cardiovascular disease: systematic review and meta-analysis. J Med Internet Res 2021; 23: e24190.
13.
Arshed M, Mahmud AB, Minhat HS, Ying LP, Umer MF. Effectiveness of mHealth interventions in medication adherence among patients with cardiovascular diseases: a systematic review. Diseases 2023; 11: 41.
14.
Hou Q, Zhao Y, Wu Y. Medication adherence trajectories and clinical outcomes in patients with cardiovascular disease: a systematic review and meta-analysis. J Glob Health 2025; 15: 04145.
15.
Rojas-Reyes J, Flórez-Flórez M. Adesão ao tratamento e qualidade de vida em pessoas com infarto agudo de miocárdio. Aquichan 2016; 16: 328-39.
16.
Ricarte Cavalcante L, Leite Brito L, Fraga-Maia H. Functional health literacy: protective role in adherence to treatment for hypertensive patients. Rev Bras em Promoção da Saúde 2020; 33: 1-12.
17.
Castillo Costa Y, Mauro V, Barsotti A, et al. Predictores de la elección de nuevos anticoagulantes directos en la fibrilación auricular y su adherencia al año. Rev Argent Cardiol 2019; 87: 365-70.
18.
van der Laan D, Elders P, Boons C, Beckeringh J, Nijpels G, Hugtenburg J. Factors associated with antihypertensive medication non-adherence: a systematic review. J Hum Hypertens 2017; 31: 687-94.
19.
Ho P, Spertus J, Masoudi F, et al. Impact of medication therapy discontinuation on mortality after myocardial infarction. Arch Intern Med 2006; 166: 1842-7.
20.
Hendzel A, Krzyżanowski F, Kłoda K, Mastalerz-Migas A, Babicki M. Facts and myths about use and effect of statins in patients with dyslipidaemia – a survey of physicians. Arch Med Sci 2026; 22 (1): 56–64.
21.
Nedeljkovic M, Mihajlovic M, Mujovic N, Lip GYH, Potpara TS. Assessment of patient-reported treatment burden in patients with coronary artery disease. Arch Med Sci 2024; 20: 1006-10.
22.
Dodani S, Clarke A, El Moudden I, Gunawardena T, Bedi N. The impact of a Telehealth-based Behavioral Lifestyle Program on hypertension control in African American participants: results from the HEALS Med-Tech randomized controlled trial. Arch Med Sci 2024; 20: 309-12.
23.
Thaarup M, Jacobsen S, Nielsen PB, et al. Adherence and persistence to antiplatelet therapy in lower extremity peripheral arterial disease: a danish population based cohort study. Eur J Vasc Endovasc Surg 2024; 67: 948-57.
| eISSN: | 1896-9151 |
| ISSN: | 1734-1922 |
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
